Chemoinformaics analysis of ACETIC-ACID-ETHYL-ESTER
| Molecular Weight | 203.241 | nRot | 3 |
| Heavy Atom Molecular Weight | 190.137 | nRig | 11 |
| Exact Molecular Weight | 203.095 | nRing | 2 |
| Solubility: LogS | -3.185 | nHRing | 1 |
| Solubility: LogP | 2.538 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 31.4123 |
| nHD | 0 | BPOL | 17.3557 |
| QED | 0.716 |
| Synth | 1.822 |
| Natural Product Likeliness | -1.514 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.308 |
| MDCK | 0.0000392 |
| BBB | 0.889 |
| PPB | 0.886578 |
| VDSS | 1.195 |
| FU | 0.117571 |
| CYP1A2-inh | 0.991 |
| CYP1A2-sub | 0.537 |
| CYP2c19-inh | 0.963 |
| CYP2c19-sub | 0.095 |
| CYP2c9-inh | 0.741 |
| CYP2c9-sub | 0.183 |
| CYP2d6-inh | 0.621 |
| CYP2d6-sub | 0.306 |
| CYP3a4-inh | 0.217 |
| CYP3a4-sub | 0.301 |
| CL | 12.536 |
| T12 | 0.689 |
| hERG | 0.093 |
| Ames | 0.059 |
| ROA | 0.035 |
| SkinSen | 0.383 |
| Carcinogencity | 0.366 |
| EI | 0.536 |
| Respiratory | 0.048 |
| NR-Aromatase | 0.019 |
| Antiviral | No |
| Prediction | 0.680132 |